The Venture Codex Logo

The Venture Codex

Ackermans & van Haaren

Begijnenvest 113, Antwerpen, 2000, Belgium

Overview

Diversified investment group in marine, banking, real estate, and energy.

Founded

1876

Deals ยท 12mo

2

Links

WebsiteLinkedIn

Stage focus

Seed
Series B

Geographic focus

Belgium
Germany
India
The Netherlands

Sector focus

Banking
Infrastructure
Real Estate

Investment portfolio

8rounds
NAMEDATESIZE
Medikabazaar
Feb 2026Participated
$55 MOther Equity
DISCO Pharmaceuticals
Dec 2025Led
$42 MSeed
MRM Health
Sep 2025Participated
$64 MSeries B
Confo Therapeutics
Jul 2024Led
$65 MSeries B
Vico Therapeutics
Jan 2024Led
$59 MSeries B
AstriVax
Aug 2022Participated
$30 MSeed
Indigo Diabetes
Jul 2020Participated
$44 MSeries B
Biotalys
Jul 2019Participated
$39 MSeries C
Medikabazaar
Feb 2026Participated
$55 MOther Equity
DISCO Pharmaceuticals
Dec 2025Led
$42 MSeed
MRM Health
Sep 2025Participated
$64 MSeries B
Confo Therapeutics
Jul 2024Led
$65 MSeries B
Vico Therapeutics
Jan 2024Led
$59 MSeries B
AstriVax
Aug 2022Participated
$30 MSeed
Indigo Diabetes
Jul 2020Participated
$44 MSeries B
Biotalys
Jul 2019Participated
$39 MSeries C
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ackermans & van Haaren: 8 funding rounds are recorded in the selected participation categories.All available history.
Ackermans & van Haaren: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed11
Series B22
Series C+01
Other Equity01

Monthly Deal Activity

Ackermans & van Haaren: 8 deals are recorded across 88 months.All available history.
Ackermans & van Haaren: 8 deals are recorded across 88 months. All available history
MonthDeals
Jul '191
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '251
Jan '260
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Ackermans & van Haaren: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ackermans & van Haaren: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Networks, Cloud & Communication1
Manufacturing1
E-Commerce & Retail1
Food & Agriculture1

Deal Size Distribution

Ackermans & van Haaren: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ackermans & van Haaren: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M4
$50M-$100M4
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Ackermans & van Haaren: Europe has the largest recorded deal count among the displayed regions (7 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Ackermans & van Haaren: Europe has the largest recorded deal count among the displayed regions (7 deals). All available history
RegionDeals
Europe7
India1
Ackermans & van Haaren: 20 co-investors are shown, with Fund+ sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Ackermans & van Haaren: 20 co-investors are shown, with Fund+ sharing 3 recorded deals. All available history
Co-investorShared deals
Fund+3
BNP Paribas Fortis Private Equity2
PMV2
Qbic2
Sofinnova Partners2
V-Bio Ventures2
AbbVie Ventures1
Agri Investment Fund1
ATHOS1
Biocodex1
BioGeneration Ventures1
Biovest1
British International Investment1
Capricorn Investment Group1
Capricorn Venture Partners1
Creaegis1
Driehaus Capital Management1
Droia Ventures1
EQT Life Sciences (LSP)1
Eurazeo1

Investment Strategy

Ackermans & van Haaren: Led accounts for 38% and participating for 63% of round participation.All available history.
Ackermans & van Haaren: Led accounts for 38% and participating for 63% of round participation. All available history
CategoryDeals (count)Share (%)
Led338%
Participating563%
Ackermans & van Haaren: Single-lead accounts for 33% and co-led for 67% of lead dynamics.All available history.
Ackermans & van Haaren: Single-lead accounts for 33% and co-led for 67% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead133%
Co-led267%

Team

Jeroen Vangindertael

Investment Manager

Lenny Van Steenhuyse
Luc Bertrand

CEO

Matthias De Raeymaeker

Investment manager

Philip Heylen

Business Development Manager

Pierre Macharis

Non Executive Director

Tom Bamelis

CFO